Search Results for: "plos one"

Cancer researcher faked data for 24 images in work funded by nine NIH grants: Federal watchdog

A cancer researcher faked data in a grant application, her PhD thesis, and seven published papers, according to the U.S. Office of Research Integrity. Toni Brand, who earned her PhD from the University of Wisconsin and served as a postdoc at the University of California, San Francisco (UCSF), “engaged in research misconduct by knowingly or … Continue reading Cancer researcher faked data for 24 images in work funded by nine NIH grants: Federal watchdog

Five studies linked to Cassava Sciences retracted

A researcher at the center of questions about a biotech’s controversial experimental treatment for Alzheimer’s disease has lost five papers in PLOS One.  The journal says it is retracting the articles, by Hoau-Yan Wang and colleagues, over concerns about the integrity of the data and the images in the papers. Wang does not agree with … Continue reading Five studies linked to Cassava Sciences retracted

Weekend reads: False data in Columbia rankings?; data service accused of intimidating researchers; preprint server removes ‘inflammatory’ papers

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Study of cryotherapy for COVID-19 anosmia fails the sniff test Psych journal in revolt as it publishes paper saying masturbation and gay sex are harmful Award-winning Berkeley postdoc faked data, says federal watchdog Murder … Continue reading Weekend reads: False data in Columbia rankings?; data service accused of intimidating researchers; preprint server removes ‘inflammatory’ papers

Courage and correction: how editors handle – and mishandle – errors in their journals

Last year, our group noticed an improper analysis of a purported cluster randomized trial (cRCT) in eClinicalMedicine, a Lancet journal, and requested deidentified raw data from the authors to conduct a proper analysis for the study design.  Things were off to a good start. The authors shared their data immediately – which is commendable and, … Continue reading Courage and correction: how editors handle – and mishandle – errors in their journals

Journal mulls expression of concern for Cassava Sciences paper

A journal is considering issuing an expression of concern for a 2005 paper by authors tied to a company that’s now under investigation for fraud, Retraction Watch has learned.  [See an update on this post (bottom).] The article, “Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ … Continue reading Journal mulls expression of concern for Cassava Sciences paper

Weekend reads, double edition: Scamming journals to publish gibberish; a whole issue with nothing but retractions; ‘the unbearable lightness of scientometric indices’

Welcome to another edition of Weekend Reads. Because our site was down for several days starting last Saturday morning, there was no Weekend Reads last week, and this is a double edition. Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. … Continue reading Weekend reads, double edition: Scamming journals to publish gibberish; a whole issue with nothing but retractions; ‘the unbearable lightness of scientometric indices’

Scale whose copyright owner defends zealously falls under scrutiny — and journal takes two years to publish a critique

As long-time readers of this blog know, we’ve spilled more than a few pixels on the work of Donald Morisky. His Morisky Medication Adherence Scale (MMAS) has been a financial boon to himself — and the bane of many researchers who have been forced to either retract papers or pay Morisky what they consider to … Continue reading Scale whose copyright owner defends zealously falls under scrutiny — and journal takes two years to publish a critique

Biotech’s data supporting Alzheimer’s trials under scrutiny

A law firm known for filing shareholder suits says that data supporting a drug company’s plan for trials of its experimental treatment for Alzheimer’s disease show evidence of manipulation. Stock in the company, Cassava Biosciences, tumbled yesterday after the FDA posted material from the firm, Labaton Sucharow, and a top research integrity expert tells Retraction … Continue reading Biotech’s data supporting Alzheimer’s trials under scrutiny

‘A very unfortunate event’: Paper on COVID-19 vaccine hesitancy retracted

A group of researchers in Canada and India have lost a paper on vaccine hesitancy and Covid-19 because they didn’t have the proper license to mine a database of news articles used in the study.  The paper, “Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach,” was published in PLOS ONE on June … Continue reading ‘A very unfortunate event’: Paper on COVID-19 vaccine hesitancy retracted

Two years: That’s how long it took a PLOS journal to flag a paper after a sleuth raised concerns

Two years after being alerted to a questionable figure in a 2016 paper by a group with a questionable publication history, a PLOS journal has issued an expression of concern about the article. The paper, “Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway,” was published in  … Continue reading Two years: That’s how long it took a PLOS journal to flag a paper after a sleuth raised concerns